The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:49
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
下载
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [31] Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma
    Speicher, Paul J.
    Englum, Brian R.
    Ganapathi, Asvin M.
    Mulvihill, Michael S.
    Hartwig, Matthew G.
    Onaitis, Mark W.
    D'Amico, Thomas A.
    Berry, Mark F.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 181 - 188
  • [32] Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
    Schagen, SB
    van Dam, FSAM
    Muller, MJ
    Boogerd, W
    Lindeboom, J
    Bruning, PF
    CANCER, 1999, 85 (03) : 640 - 650
  • [33] Adjuvant radiation therapy improves survival for gallbladder carcinoma
    Mojica, P
    Smith, D
    Ellenhorn, J
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 23 - 24
  • [34] SERIOUS POSTOPERATIVE COMPLICATIONS AFTER ESOPHAGECTOMy FOR ESOPHAGEAL CARCINOMA: ANALYSIS OF RISK FACTORS
    Armestar, Fernando
    Mesalles, Eduard
    Font, Albert
    Arellano, Antonio
    Roca, Josep
    Klamburg, Jordi
    Fernandez-Llamazares, Jaime
    MEDICINA INTENSIVA, 2009, 33 (05) : 224 - 232
  • [35] ADJUVANT POSTOPERATIVE RADIATION-THERAPY FOR COLONIC-CARCINOMA
    WILLETT, CG
    TEPPER, JE
    SKATES, SJ
    WOOD, WC
    ORLOW, EC
    DUTTENHAVER, JR
    ANNALS OF SURGERY, 1987, 206 (06) : 694 - 698
  • [36] Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma
    McDowell, Lachlan J.
    Huang, Shao Hui
    Xu, Wei
    Che, Jiahua
    Wong, Rebecca K. S.
    Brierley, James
    Kim, John
    Cummings, Bernard
    Waldron, John
    Bayley, Andrew
    Hansen, Aaron
    Witterick, Ian
    Ringash, Jolie
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 186 - 195
  • [37] Survival and toxicity with intensity modulated radiation therapy (IMRT) and chemotherapy for esophageal carcinoma, with or without surgery
    Kowalchik, Kristin
    Johnson, Elizabeth
    Kim, George P.
    Smith, C. Daniel
    Kim, Siyong
    Paryani, Nitesh N.
    Ko, Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [38] Adjuvant chemotherapy and outcomes in esophageal carcinoma
    Saeed, Nadia A.
    Mellon, Eric A.
    Meredith, Kenneth L.
    Hoffe, Sarah E.
    Shridhar, Ravi
    Frakes, Jessica
    Fontaine, Jacque-Pierre
    Pimiento, Jose M.
    Kothari, Nishi
    Almhanna, Khaldoun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (05) : 816 - 824
  • [39] Does adjuvant pelvic radiation therapy improve survival in patients with uterine serous carcinoma who received adjuvant chemotherapy?
    Mahdi, H.
    Rose, P. G.
    Gonzalez, S.
    DeBernardo, R.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 26 - 26
  • [40] The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer
    Kubo, Yuto
    Tanaka, Koji
    Yamasaki, Makoto
    Yamashita, Kotaro
    Makino, Tomoki
    Saito, Takuro
    Yamamoto, Kazuyoshi
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (11)